Gotowa bibliografia na temat „Cardiovascular diseases”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cardiovascular diseases”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cardiovascular diseases"
Subramanian, Geetha, Balaji Lohiya i Dharmendra Jain. "Sex Hormones and Cardiovascular Diseases". Journal of Cardiovascular Medicine and Surgery 3, nr 2 (2017): 198–201. http://dx.doi.org/10.21088/jcms.2454.7123.3217.19.
Pełny tekst źródłaBasit Ashraf, Muhammad Abdul, Razia Rizwan, Mahwish Arooj, Arif Malik i Sarmad Bashir. "CARDIOVASCULAR DISEASES". Professional Medical Journal 23, nr 11 (10.11.2016): 1400–1411. http://dx.doi.org/10.29309/tpmj/2016.23.11.1770.
Pełny tekst źródłaBognolo, G. "Cardiovascular diseases". BMJ 327, nr 7427 (6.12.2003): 1354—a—1354. http://dx.doi.org/10.1136/bmj.327.7427.1354-a.
Pełny tekst źródłaArcher, L. Nicholas J. "Cardiovascular diseases". Current Opinion in Pediatrics 2, nr 1 (luty 1990): 91–94. http://dx.doi.org/10.1097/00008480-199002000-00017.
Pełny tekst źródłaFLACK, J. "Cardiovascular diseases". American Journal of Hypertension 10, nr 4 (kwiecień 1997): 227A. http://dx.doi.org/10.1016/s0895-7061(97)89485-x.
Pełny tekst źródłaKakkar, Rahul, i Richard T. Lee. "Cardiovascular diseases". Drug Discovery Today: Disease Models 4, nr 4 (grudzień 2007): 163–64. http://dx.doi.org/10.1016/j.ddmod.2008.04.001.
Pełny tekst źródłaMacphee, Colin H., i Alan Daugherty. "Cardiovascular diseases". Drug Discovery Today: Therapeutic Strategies 5, nr 1 (marzec 2008): 1–3. http://dx.doi.org/10.1016/j.ddstr.2008.11.002.
Pełny tekst źródłaAlpert, Joseph S. "Cardiovascular Diseases". JAMA: The Journal of the American Medical Association 254, nr 16 (25.10.1985): 2264. http://dx.doi.org/10.1001/jama.1985.03360160096020.
Pełny tekst źródłaViera, Anthony J. "Cardiovascular Diseases". Primary Care: Clinics in Office Practice 51, nr 1 (marzec 2024): i. http://dx.doi.org/10.1016/s0095-4543(23)00109-4.
Pełny tekst źródłaAslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich i Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases". American Journal of Medical Sciences and Pharmaceutical Research 03, nr 06 (10.06.2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.
Pełny tekst źródłaRozprawy doktorskie na temat "Cardiovascular diseases"
Gadd, Malin. "Cardiovascular diseases in immigrants in Sweden /". Stockholm : Neurotec, Center for family and community medicine, Karolinska institutet, 2006. http://diss.kib.ki.se/2006/91-7140-627-1/.
Pełny tekst źródłaGrytsiuk, M. І. "Life and cardiovascular diseases". Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18306.
Pełny tekst źródłaAgyemang, Edmund Adjei, Priscilla Okoh i K. O. Bobkovych. "Cardiovascular Diseases in Ghana". Thesis, «Інновації в медицині»: Тези доповідей 85-ої науково-практичної конференції студентів і молодих вчених із міжнародною участю (м. Івано-Франківськ, 24-25 березня 2016 р.). – м. Івано-Франківськ, 2016, 2016. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/11247.
Pełny tekst źródłaКафедра пропедевтики внутрішніх хвороб
Abdi, Faduma Najmo Abdulrahman, i K. O. Bobkovych. "Cardiovascular diseases in Somalia". Thesis, «Інновації в медицині»: Тези доповідей 85-ої науково-практичної конференції студентів і молодих вчених із міжнародною участю (м. Івано-Франківськ, 24-25 березня 2016 р.). – м. Івано-Франківськ, 2016, 2016. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/11248.
Pełny tekst źródłaКафедра пропедевтики внутрішніх хвороб
Yiu, Kai-hang, i 姚啟恆. "Cardiovascular manifestations in systemic inflammatory diseases". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48541011.
Pełny tekst źródłapublished_or_final_version
Medicine
Master
Doctor of Medicine
Li, Wai-sum Rachel, i 李蕙琛. "Effects of abacavir on cardiovascular system". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B46330288.
Pełny tekst źródłaWang, Qianyi. "Fatty Acids, Cardiovascular Diseases, and Diabetes Mellitus". Thesis, Harvard University, 2015. http://nrs.harvard.edu/urn-3:HUL.InstRepos:14117764.
Pełny tekst źródłaBIFFI, ANNALISA. "Antidepressants and the risk of cardiovascular diseases". Doctoral thesis, Università degli Studi di Milano-Bicocca, 2018. http://hdl.handle.net/10281/199081.
Pełny tekst źródłaDepression is considered an important public health issue. Nowadays, about 300 million people are affected by depressive disorders and a quarter of them just in Europe. Antidepressant (AD) treatment like tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs) or newer atypical antidepressants (NAAs) seems to be the most appropriate therapy in order to treat depressive symptoms. In the first study, a synthesis of the available scientific literature was performed on the possible association between use of AD and cardiovascular diseases (CVD). A search of published observational studies was carried out using terms directly related with cardiovascular and antidepressive field. In addition, the quality of the included studies, the heterogeneity among them as well as the presence of publication bias was evaluated. The second part of the thesis regards the studies conducted within the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) project, where data from different regional healthcare utilization databases involved in the Italian Group for Appropriate Drug Prescription in the Elderly (I-GrADE) was used. The project is focused on the evaluation of inappropriate prescribing in a population of elderly hospitalized with a diagnosis of CVD. In the second study, nested-case control studies were applied for the evaluation of the role of AD respect to the occurrence of CVD, among the elderly population. Sensitivity analyses were performed, like a Monte Carlo Sensitivity Analysis (MCSA), which quantified the potential bias introduced by a particular confounder (smoking factor) and by changing the length of AD exposure’s window. In the third study, the acute effect of AD treatment was evaluated respect to the onset of arrhythmia. The cohort selection was restricted to the new AD users who did not developed a previous event of arrhythmia. Nested case-control and case-crossover studies were applied and estimates were adjusted for drug prescriptions and hospitalizations. Sensitivity analyses were performed by using different criteria to define the outcome of interest or by changing length of AD exposure’s window. In the fourth study, we focused on the role of AD medication respect to mortality. The possible link between adherence to AD and increased or decreased risk of mortality was tested among the elderly cohort. The selection was restricted to elderly who were all AD users and started AD therapy since cohort recruitment. A Cox model was applied and the combined levels of adherence to AD and co-treatments were evaluated during observation time. Estimates were adjusted for several variables such as the polypharmacy. Then, sensitivity analyses were performed on the basis of AD coverage’s definition. The results of the meta-analysis showed a significant increased risk of cerebrovascular disease and acute heart failure respectively for SSRIs and TCA users. Then, these results were confirmed by the observational studies performed within the AIFA Project. A positive relation was found between AD exposure and CVD in a cohort of elderly patients already affected by a CVD, in particular a proarrhythmic effect of AD exposure was revealed by our estimates. Finally, adherence to AD treatment was associated with a decreased risk of death by considering different levels of adherence to co-treatments assumed during the observation time. In conclusion, these studies showed that the use of AD could increase the risk of several CV disease, therefore, physicians need to carefully monitor their patients to ensure a correct assumption of the drugs and concurrently try to prevent the onset of CV outcomes. Since any potential increased risk may result in a considerable impact, the risk effect estimates provided by these studies may support both clinical practices and regulatory activities.
Rosenlund, Mats. "Environmental factors in cardiovascular disease /". Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-292-6/.
Pełny tekst źródłaGobin, Reeta Rukmini Devi. "Metabolic syndrome and cardiovascular disease". Thesis, University of Cambridge, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.610102.
Pełny tekst źródłaKsiążki na temat "Cardiovascular diseases"
Murad, Ferid, Atta-ur-Rahman i Ka Bian, red. Cardiovascular Diseases. UAE: Bentham Science Publishers Ltd., 2017. http://dx.doi.org/10.2174/97816810848931170101.
Pełny tekst źródłaOffice, Great Britain Welsh, Gwent Health Authority i Protocol Enhancement Project, red. Cardiovascular diseases. [Cardiff]: [Welsh Office], 1998.
Znajdź pełny tekst źródłaTaylor, Robert B., Alan K. David, D. Melessa Phillips, Scott A. Fields i Joseph E. Scherger, red. Taylor’s Cardiovascular Diseases. New York: Springer-Verlag, 2005. http://dx.doi.org/10.1007/b138863.
Pełny tekst źródłaAkinkugbe, O. O. Cardiovascular disease. Oxford: Blackwell Scientific, 1987.
Znajdź pełny tekst źródłaEvans, Mary Jane R. Cardiovascular nursing. Springhouse, Pa: Springhouse Corp., 1989.
Znajdź pełny tekst źródłaBaune, Bernhard T., i Phillip J. Tully, red. Cardiovascular Diseases and Depression. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32480-7.
Pełny tekst źródłaEliseev, Oleg M. Cardiovascular Diseases and Pregnancy. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73605-6.
Pełny tekst źródłaLenzi, S., i G. C. Descovich, red. Atherosclerosis and Cardiovascular Diseases. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0.
Pełny tekst źródłaVeronese, Nicola, red. Frailty and Cardiovascular Diseases. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-33330-0.
Pełny tekst źródłaAndrade, Jadelson, Fausto Pinto i Donna Arnett, red. Prevention of Cardiovascular Diseases. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22357-5.
Pełny tekst źródłaCzęści książek na temat "Cardiovascular diseases"
Bidulescu, Aurelian, i Methode Bacanamwo. "Cardiovascular Diseases". W Nutrition in Epigenetics, 173–87. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9780470959824.ch10.
Pełny tekst źródłaLadd, Susanne, Harald Kramer, Christoph R. Becker, Norbert Weiss i Ulrich Hoffmann. "Cardiovascular Diseases". W Screening and Preventive Diagnosis with Radiological Imaging, 149–82. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-49831-5_9.
Pełny tekst źródłaTiwari, Jawahar L., i Paul I. Terasaki. "Cardiovascular Diseases". W HLA and Disease Associations, 352–62. New York, NY: Springer New York, 1985. http://dx.doi.org/10.1007/978-1-4613-8545-5_15.
Pełny tekst źródłaWolman, Benjamin B. "Cardiovascular Diseases". W Psychosomatic Disorders, 133–43. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5520-5_15.
Pełny tekst źródłaHoffman, Richard, i Mariette Gerber. "Cardiovascular Diseases". W The Mediterranean Diet, 258–92. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118785027.ch11.
Pełny tekst źródłaHupp, Wendy S. "Cardiovascular Diseases". W The ADA Practical Guide to Patients with Medical Conditions, 25–42. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2015. http://dx.doi.org/10.1002/9781119121039.ch2.
Pełny tekst źródłaMenotti, Alessandro. "Cardiovascular Diseases". W The Mediterranean Diets in Health and Disease, 232–51. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-6497-9_12.
Pełny tekst źródłaVerjans, Johan, Wouter B. Veldhuis, Gustavo Carneiro, Jelmer M. Wolterink, Ivana Išgum i Tim Leiner. "Cardiovascular Diseases". W Artificial Intelligence in Medical Imaging, 167–85. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-94878-2_13.
Pełny tekst źródłaLancaster, H. O. "Cardiovascular Diseases". W Expectations of Life, 252–65. New York, NY: Springer New York, 1990. http://dx.doi.org/10.1007/978-1-4612-1003-0_25.
Pełny tekst źródłaRaczynski, James M., Martha M. Phillips, Carol E. Cornell, M. Janice Gilliland, Bonnie Sanderson i Vera Bittner. "Cardiovascular Diseases". W Handbook of Health Promotion and Disease Prevention, 231–59. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4615-4789-1_12.
Pełny tekst źródłaStreszczenia konferencji na temat "Cardiovascular diseases"
Vinzey, Hrishikesh, Aditya Tidke, Prachi Palsodkar, Soham Kottawar, Yogita Dubey i Punit Fulzele. "Predictive Analysis of Cardiovascular Diseases". W 2022 International Conference on Emerging Trends in Engineering and Medical Sciences (ICETEMS). IEEE, 2022. http://dx.doi.org/10.1109/icetems56252.2022.10093374.
Pełny tekst źródłaWang, Jingying. "Lipoproteins and Atherosclerotic Cardiovascular Diseases". W International Conference on Health Big Data and Intelligent Healthcare. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011371300003438.
Pełny tekst źródłaКарпин, Владимир Александрович, i Ольга Ивановна Шувалова. "INTESTINAL MICROBIOTA AND CARDIOVASCULAR DISEASES". W Высокие технологии и инновации в науке: сборник статей LII международной научной конференции (Санкт-Петербург, Май 2024). Crossref, 2024. http://dx.doi.org/10.37539/240527.2024.23.78.002.
Pełny tekst źródłaJo-Avila, Miguel, Ahmed Al-Jumaily i Jun Lu. "Predictive Cardiovascular Model With Blood Flow Measurements". W ASME 2015 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2015. http://dx.doi.org/10.1115/imece2015-51993.
Pełny tekst źródłaMesihović-Dinarević, Senka. "WHAT IS NEW IN CARDIOVASCULAR MEDICINE?" W Symposium with International Participation HEART AND … Akademija nauka i umjetnosti Bosne i Hercegovine, 2019. http://dx.doi.org/10.5644/pi2019.181.03.
Pełny tekst źródłaLebedeva, O. D. "Non-medicinal technologies for cardiovascular diseases". W Arbat readings. Знание-М, 2020. http://dx.doi.org/10.38006/907345-01-0.2020.66.71.
Pełny tekst źródłaHennig, Andreas, Gerd vom Bogel i Anton Grabmaier. "Sensor transponder system for cardiovascular diseases". W 2012 IEEE International Conference on RFID-Technologies and Applications (RFID-TA). IEEE, 2012. http://dx.doi.org/10.1109/rfid-ta.2012.6404567.
Pełny tekst źródłaYAMAGUCHI, TAKAMI, HITOSHI KONDO, YUJI SHIMOGONYA, YOHSUKE IMAI, NORIAKI MATSUKI i TAKUJI ISHIKAWA. "COMPUTATIONAL BIOMECHANICS FOR INVESTIGATING CARDIOVASCULAR DISEASES". W Proceedings of the Tohoku University Global Centre of Excellence Programme. PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO., 2009. http://dx.doi.org/10.1142/9781848163539_0004.
Pełny tekst źródłaChocarro, Luisa, Ester Blanco, Hugo Arasanz, Leticia Fernández Rubio, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro, Grazyna Kochan i David Escors. "LAG-3 Role in Cardiovascular Diseases". W MOL2NET'22, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 8th ed. - MOL2NET: FROM MOLECULES TO NETWORKS. Basel, Switzerland: MDPI, 2022. http://dx.doi.org/10.3390/mol2net-08-12448.
Pełny tekst źródłaBhupalam, Manideep, Hari Charan Reddy Manthoor i Ananthakrishna Thalengala. "Classification of Cardiovascular Diseases using PCG". W 2023 International Conference on Modeling, Simulation & Intelligent Computing (MoSICom). IEEE, 2023. http://dx.doi.org/10.1109/mosicom59118.2023.10458727.
Pełny tekst źródłaRaporty organizacyjne na temat "Cardiovascular diseases"
Wang, Yuchen. How does Veteran Status Affect Risk of Cardiovascular Diseases? Ames (Iowa): Iowa State University, styczeń 2019. http://dx.doi.org/10.31274/cc-20240624-843.
Pełny tekst źródłaLampley, Katrice, i Nicole Therrien. "Geisinger Ambulatory Pharmacy Care Program Field Notes". National Center for Chronic Disease Prevention and Health Promotion (U.S.)., 2023. http://dx.doi.org/10.15620/cdc:126232.
Pełny tekst źródłaO’Connell, Joan, Jennifer Rockell, Margaret Reid, Kathleen Harty, Marcelo Perraillon i Spero Manson. Improving Health Outcomes among Native Americans with Diabetes and Cardiovascular Diseases. Patient-Centered Outcomes Research Institute (PCORI), listopad 2020. http://dx.doi.org/10.25302/11.2020.ad.13046451.
Pełny tekst źródłaZhang, Mingzhu, Wujisiguleng Bao, Luying Sun, Zhi Yao i Xiyao Li. Efficacy and safety of finerenone in chronic kidney disease associated with type 2 diabetes: meta-analysis of randomized clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2022. http://dx.doi.org/10.37766/inplasy2022.3.0020.
Pełny tekst źródłaJin, Soyeon, i Peter Kang. A Systemic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2024. http://dx.doi.org/10.37766/inplasy2024.7.0064.
Pełny tekst źródłaLiu, Yangjun, Wei Xie, Zbigniew Ossowski, Juan Li, Juan Yang, Yiming Luo, Xia Wu i Liying Liu. Physical activity, abdominal obesity and inflammatory response in the elderly: a systematic review and meta-analysis of randomized-controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, marzec 2023. http://dx.doi.org/10.37766/inplasy2023.3.0051.
Pełny tekst źródłaGupta, Shweta. Obesity: A Lifestyle Choice or a Disease? Nature Library, październik 2020. http://dx.doi.org/10.47496/nl.blog.07.
Pełny tekst źródłaCabrera-Aguilera, Ignacio, Gonzalo Latin-Rivera, Rodrigo Torres-Castro, Camen Gloria Zambrano, Isabel Blanco, Sonia Ruiz-Bustillo, Lluis Recasens, Nuria Farré Lopez, Elena Gimeno-Santos i Jordi Vilaró. Effects of exercise on the expression of angiogenesis-precursor biomarkers in cardiovascular diseases: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0112.
Pełny tekst źródłaKeshav, Dr Geetha, Dr Suwaibah Fatima Samer, Dr Salman Haroon i Dr Mohammed Abrar Hassan. TO STUDY THE CORRELATION OF BMI WITH ABO BLOOD GROUP AND CARDIOVASCULAR RISK AMONG MEDICAL STUDENTS. World Wide Journals, luty 2023. http://dx.doi.org/10.36106/ijar/2405523.
Pełny tekst źródłaFEDOTKINA, S. A., O. V. MUZALEVA i E. V. KHUGAEVA. RETROSPECTIVE ANALYSIS OF THE USE OF TELEMEDICINE TECHNOLOGIES FOR THE PREVENTION, DIAGNOSIS AND TREATMENT OF HYPERTENSION. Science and Innovation Center Publishing House, 2021. http://dx.doi.org/10.12731/978-0-615-67320-2-4-22.
Pełny tekst źródła